Conversations surrounding COVID-19 and the use of diagnostics continue to dominate the media, bringing greater familiarity to the value that diagnostic information has in the healthcare pathway. This latest article released by the New York Times includes experts like Mark Miller, MD, chief medical officer at bioMérieux, who discusses the need of today's clinical diagnostics to simultaneously test for more pathogens like COVID-19 for optimal infectious disease management. Labs are preparing for testing demands to skyrocket when the more typical seasonal flu strains reemerge in the fall. Front-line healthcare professionals want to know, which test should I use?

Mark Miller, MD, Chief Medical Officer at bioMérieux

The New York Times
May 11, 2021